Similar findings were reported in other studies; in 118 patients with ovarian cancer treated with platinum‐based chemotherapy, the GSTP1 c.313 A>G, the A allele was a significant risk factor for grade 3 or 4 hematological toxicity. This evidence concerns the gene GSTP1 and ovarian cancer.